Newsfeeds Archive - Page 410 of 19074

2 minute read

Morgan Stanley’s E*Trade Mulls Roaring Kitty Ban Over Alleged Stock Manipulation: Report

June 3, 4:22 PM

Morgan Stanley may ban Keith Gill from E*Trade due to concerns of manipulating meme stock prices through social media. Gill's actions have led to increased volatility and sparked debates within the firm.

AMC

2 minute read

Bitcoin, Ethereum, Dogecoin Spike, But: ‘Monday Pump And Then Tuesday Dump Scenario Is Possible,’ Warns Trader

By Khyathi Dalal

June 3, 4:20 PM

Cryptocurrency markets have started the week in green, as traders anticipate the impact of Ethereum spot ETFs. Prices as of 4 p.m. ET:

$DOGE

1 minute read

Inogen’s Study Demonstrating The Association Of Portable Oxygen Therapy With Decreased Mortality And Increased Cost-Effectiveness Ratio Published In The Journal Pulmonary Therapy

By Benzinga Newsdesk

June 3, 4:20 PM

Inogen, Inc. (NASDAQ:INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today shared the results of a study published in the journal Pulmonary Therapy,

INGN

1 minute read

Healthcare Realty Trust Provides Update On Capital Allocation Progress, Has Contributed 10 Properties To The KKR JV That Have Generated $227M Of Proceeds; Has Additional Transactions Under Contract And Letters Of Intent That Are Expected To Generate Fu…

By Benzinga Newsdesk

June 3, 4:16 PM

$227 million of proceeds from contributions to KKR JV Repurchased shares totaling over $175 millionNASHVILLE, Tenn., June 03, 2024 (GLOBE NEWSWIRE) -- Healthcare Realty Trust Incorporated (NYSE:HR) announced in

3 minute read

This Is What Whales Are Betting On Taiwan Semiconductor

By Benzinga Insights

June 3, 4:15 PM

Investors with a lot of money to spend have taken a bullish stance on Taiwan Semiconductor (NYSE:TSM). And…

TSM

3 minute read

Looking At FedEx’s Recent Unusual Options Activity

By Benzinga Insights

June 3, 4:15 PM

Whales with a lot of money to spend have taken a noticeably bullish stance on FedEx. Looking at…

FDX

1 minute read

FibroGen Inks Clinical Trial Supply Agreement With Regeneron Pharmaceuticals To Evaluate FibroGen’s Immuno-Oncology Assets, FG-3165 And FG-3175, In Combination With LIBTAYO In Upcoming Clinical Trials

By Benzinga Newsdesk

June 3, 4:09 PM

FibroGen to evaluate FG-3165, an anti-galectin 9 (Gal9) monoclonal antibody (mAb), as monotherapy treatment as well as in combination with LIBTAYO® in patients with select solid tumorsFibroGen to evaluate FG-3175,

FGEN

1 minute read

Ascendis Pharma To Present New Data And Updated Results From Phase 1/2 IL-Believe Trial At ASCO 2024

By Benzinga Newsdesk

June 3, 4:05 PM

- 40% of efficacy-evaluable patients (2 out of 5) in the initial cohort of patients with anti-PD-1 refractory melanoma treated with TransCon IL-2 β/γ in combination with TransCon TLR7/8 Agonist exhibited

ASND

1 minute read

Scholar Rock To Present New Data From SRK-181 Phase 1 DRAGON Trial At ASCO 2024 Annual Meeting

By Benzinga Newsdesk

June 3, 4:01 PM

Promising objective response rates (ORR) were observed in multiple tumor types in anti-PD-(L)1 resistant patientsAnalysis of baseline biomarker data in clear cell renal cell carcinoma (ccRCC) patients reveals a doubling

SRRK